Skip to main content

Table 1 AKT1, TSC2, mTOR, and S6K expression in patients with premature ovarian insufficiency vs. fertile controls

From: Activation of AKT/mammalian target of rapamycin signaling in the peripheral blood of women with premature ovarian insufficiency and its correlation with FMR1 expression

 

POI (n = 74)

FC (n = 56)

 

Gene

Median (25th to 75th percentiles)

Median (25th to 75th percentiles)

pa

FMR1

3.539 (2.487–4.594)

3.400 (2.374–4.373)

0.382

AKT1

4.797 (3.972–5.553)

3.590 (1.724–5.342)

0.009

TSC2

3.678 (2.942–4.077)

2.917 (1.269–3.691)

0.001

mTOR

2.533 (1.819–3.996)

1.856 (0.517–3.255)

0.002

S6K

1.824 (1.564–2.281)

1.538 (0.574–2.029)

0.001

  1. Expression of AKT1, TSC2, mTOR, and S6K (relative gene expression) in peripheral blood of patients with patients with premature ovarian insufficiency and fertile controls. Abbreviations: POI premature ovarian insufficiency, FCs fertile controls. aMann-Whitney tests